Cardiology Despite the availability of effective therapies, ischaemic heart disease remains the leading cause of death around the world. Early and proper diagnosis is key to reducing cardiovascular mortality and diagnostic imaging plays a crucial role here.

Oncology According to the World Health Organization (WHO), in 2020 cancer accounted for nearly 10 million deaths worldwide – that’s almost one in every six deaths – with cancers of the lung, colon, and rectum, and prostate being the most common.

Talking Images podcast: The sustainable way – voices of action Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?

ProHance ProHance® is a macrocyclic, non-ionic gadolinium-based contrast agent, characterized by very low osmolality and viscosity.

CT Exprès CT Exprès™ Contrast Media Delivery System is the result of several years of development targeted at better satisfying customers' needs, cost containment considerations and safety concerns. 

Iomeron Iomeron® is a non-ionic, monomeric, iodine contrast agent for radiology7

Protoco2l Touch PROTOCO2L TouchTM is a unique system that fully automates the insufflation process, freeing staff for other duties. Since CO2 is rapidly absorbed, insufflation with CO2 results in improved patient comfort after the procedure.

MultiHance MultiHance® (gadobenate dimeglumine) is a gadolinium-based contrast agent (GBCA) currently approved in the European Union, Norway, and Iceland for use in diagnostic magnetic resonance imaging (MRI) of the liver in adult and in pediatric patients older than two years of age.1

Empower MR The EmpowerMR® Contrast Injection System is a state-of-the-art integrated contrast injection system designed to meet the demands of today's advanced MR procedures. 

Sonovue SonoVue® is a second-generation ultrasound contrast agent, designed and optimized for pressure resistance: this is the result of many years of research and development within Bracco.